生命倫理與管制治理的調和：以中國人類胚胎幹細胞研究管制變遷為例_

:::

詳目顯示

第 1 筆 / 總合 1 筆

/1頁

來源文獻資料
摘要
外文摘要
引文資料

題名：	生命倫理與管制治理的調和：以中國人類胚胎幹細胞研究管制變遷為例
書刊名：	國家與社會
作者：	賴沅暉
作者(外文)：	Lai, Yuan-hui
出版日期：	2013
卷期：	15
頁次：	頁63-119
主題關鍵詞：	生命科學；科學治理；幹細胞硏究；生命倫理；管制政策；China；Science governance；Stem cell research；Bioethics；Regulatory policy
原始連結：	連回原系統網址
相關次數：	被引用次數:期刊(0) 博士論文(0) 專書(0) 專書論文(0) 排除自我引用:0 共同引用:0 點閱:15

在探討為何中國在生命科學領域中，仍然在基礎建設、政策、法律、以及倫理層面上，無法隨科技進展而得以充分發展的議題上，已引發了許多不同的詮釋與論辯。中國的政策制定者在1978年改革開放後，開始接受以建構完備的法律管制與倫理準則作為策略優勢，試圖在生命科學的全球與區域競爭中取得一席之地。對此，本研究主要針對中國對於生命科學研究的管制政策發展與變遷進行分析，並以人類胚胎幹細胞研究為例，探討中國以何種方式邁向新型態的管制政策與建立政策優先性，並將焦點置於中國如何在既有的文化系絡下，建構與西方相容的科學治理體系，探討中國對於生命科學研究管制在概念建構、政策與法律制定，與執行實務上所面臨的挑戰。

以文找文

Stem cell research is a field that has attracted considerable scientific, financial investment and attention in China. It is also a field surrounded by ethical controversies and policy developments concerning cloning, the moral status of human embryos, sourcing of human embryos for research. However, the fact that the domains of life sciences in China are still seriously underdeveloped in infrastructural, policy, legal and ethical terms has prompted different explanations and debates. Some argue that this lag can be understood as expressing the need for reforms, supporting Chinese efforts to implement a policy of modernization. Others refer to a ”technological imperative” that is deeply ingrained in China's politics and ideology, especially in the areas of population and biomedicine policy. In spite of such biased assumptions, Chinese policy makers were recognized that the discontinuation of political interference with the sciences was essential for their survival, and have adopted a view that regards a sound system of legal regulations and bioethical guidelines as a strategic advantage in the competitions of the global and regional markets of life sciences. Chinese bioethicists find themselves torn between the necessity to re-create a fully-fledged regulatory policy framework that would also accommodate China's culture and aspirations to become global players in the life sciences. The result is a top-down approach in bioethics, embodied newly formulated notions of Chinese society and created on behalf of the people. This research examines efforts to develop systems of science governance in the field of stem cell research and how these relate to the cultural contexts of the country in question. This includes, on the one hand, deliberative efforts to determine what constitutes scientifically sound and ethically appropriate stem cell research, and on the other, regulatory efforts to establish rigorous systems of ethical and stem cell research.

以文找文

期刊論文
1.	Zhai, X.(2004)。ABA country report for China 2003。Eubios Journal of Asian and International Bioethics，14，5-10。
2.	Zhang, X.、Bao, Y.(2007)。Chinese scientists’ attitudes about consent policy related to human genetic databases。Turkiye Klinikleri Journal of Medical Ethics，15，63-68。
3.	丘祥興(2005)。治療性克隆及人類胚胎管理倫理問題的調查和討論。中國醫學倫理學，18(6)，4-8。延伸查詢
4.	李天東、陳桂(2006)。人胚胎幹細胞研究的倫理學問題。綿陽師範學院學報，25(3)，98-101。延伸查詢
5.	李凌松、王莉(2006)。胚胎幹細胞。生命科學，18(4)，318-322。延伸查詢
6.	沈銘賢、林志新(2005)。胚胎幹細胞研究能否得到倫理辯護。上海交通大學學報（哲學社會科學版），13(6)，5-10。延伸查詢
7.	汪忠杰、郭繼海、黃濤(2007)。探究基因研究引發的倫理問題。湖北大學學報（哲學社會科學版），34(3)，77-81。延伸查詢
8.	肖開霖(2003)。「生物世紀」的法學挑戰--羅玉中談克隆技術及其倫理準則法律化問題。中國高新區，3，27-28。延伸查詢
9.	邱仁宗、翟曉梅(2008)。在國際背景下我國倫理審查的能力建設：理念和實踐。生命倫理學通訊，12，45-49。延伸查詢
10.	孫元媛(2005)。生命倫理學及其相關公共政策的研究現狀。中國醫學倫理學，18(3)，18-21。延伸查詢
11.	曹永福、王雲嶺、楊同衛、鄭林娟、沈秀芹(2004)。我國「醫學倫理委員會」的成立背景、功能和建設建議。中國醫學倫理學，17(5)=97，31-46。延伸查詢
12.	Abbott, A.、Cyranoski, D.(2001)。China plans ‘hybrid’ embryonic stem cells。Nature，413，339。
13.	Englehardt, H.(1980)。Bioethics in the Peoples’s Republic of China。Hastings Center Report，10(2)，7-10。
14.	Englehardt, H.(2002)。The Ordination of Bioethicists as Secular Moral Experts。Social Philosophy & Policy，19(2)，59-82。
15.	Fox, R.、Swazey, J.(1984)。Medical morality is not bioethics: medical ethics in China and the United States。Perspectives in Biology and Medicine，27，336-360。
16.	Hennig, W.(2006)。Bioethics in China。European Molecular Biology Organisation，7(9)，850-854。
17.	Leggett, K.(200310)。China has tightened genetics regulation-rules ban human cloning. Moves could quiet critics of freewheeling research。Asian Wall Street Journal，13，Al。
18.	Miller, C.(2007)。Democratisation, international knowledge institutions and global governance。Governance，20(2)，325-357。
19.	Nie, J. B.(2000)。The plurality of Chinese and American medical moralities: toward an interpretive cross-cultural bioethics。Kennedy Institute of Ethics Journal，10(3)，239-260。
20.	Nie, Jing-bao(20011000)。Is Informed Consent not Applicable in China？Intellectual Flaws of the “Cultural Difference Argument”。臺灣醫學人文學刊，2(1/2)，67-74。
21.	Petryna, A.(2005)。Ethical Variability: Drug Development and Globalizing Clinical Trials。American Ethnologist，32(2)，183-197。
22.	Salter, B.(2007)。Patenting, morality and human embryonic stem cell science: bioethics and cultural politics in Europe。Regenerative Medicine，2(3)，301-311。
23.	Salter, B.(2007)。Bioethics and the global moral economy: the cultural politics of human embryonic stem cell science。Science, Technology and Human Values，32(5)，1-28。
24.	Salter, B.(2007)。The global politics of human embryonic stem cell science。Global Governance，13，277-298。
25.	Salter, B.、Jones, M.(2005)。Biobanks and bioethics: the politics of legitimateion。Journal of European Public Policy，12(4)，710-732。
26.	Sleeboom-Faulkner, M.(2008)。The changing nature of ideology in the life sciences in mainland China: case-studies of human cloning and human embryonic stem cell research (hESR) in medical textbooks (1996-2005)。BioSocieties，3(1)，21-36。
27.	Southern China National Genome Centre, Bioethics Committee(2004)。Ethical guidelines for human embryonic stem cell research。Kennedy Institute of Ethics Journal，14(1)，47-54。
28.	Thorsteinsdottir, H.、Quach, Uyen、Martin, Douglas K.、Daar, Abdallah S.、Singer, Peter A.(2004)。Introduction: promoting global health through biotechnology。Nature Biotechnology，22，DC3-DC7。
29.	Tsalikis, J.、Fritzsche, D. J.(1989)。Business Ethics: A Literature Review with a Focus on Marketing Ethics。Journal of Business Ethics，8(9)，695-743。
30.	Tsai, D. F. C.(2001)。How should doctors approach patients? A Confucian reflection on personhood。Journal of Medical Ethics，17，44-50。
31.	Vitell, Scott J.、Singhapakdi, Anusom、Thomas, James(2001)。Consumer Ethics: An Application and Empirical Testing of the Hunt-Vitell Theory of Ethics。Journal of Consumer Marketing，18(2)，153-178。
32.	Haas, Peter M.(1992)。Introduction: Epistemic Communities and International Policy Coordination。International Organization，46(1)，1-35。
33.	Rosenau, James N.(1995)。Governance in the Twenty-first Century。Global Governance，1(1)，13-43。
34.	Döring, O.(2003)。China's struggle for practical regulations in medical ethics。Nature Reviews Genetics，4，233-239。
35.	Salter, Brian、Cooper, Melinda、Dickins, Amanda(2006)。China and the global stem cell bioeconomy: An emerging political strategy?。Regenerative Medicine，1(5)，671-683。

會議論文
1.	Zhai, X.(2007)。Challenges & Governance/Regulatory Responses in China。BIONET Workshop on stem cell research，(會議日期: 2007/10/09-10/11)。Shanghai。
2.	Streitfellner, T.(2007/10/09)。Societal and Cultural Factors in Stem Cell Research: the European Landscape。BIONET Workshop on stem cell research。Shanghai。

研究報告
1.	Bionet(2010)。Ethical Governance of Biological and Biomedical Research: Chinese-European Cooperation (Final Report)。London：Bionet。
2.	Salter, B.、Waldby, C.(2007)。Contested governance in human embryonic stem cell science: uncertainty and standardisation in research and patenting?。

圖書
1.	Frankena, William K.(1973)。Ethics。Englewood Cliffs, NJ：Prentice Hall。
2.	Department of Trade and Industry(2004)。Stem cell mission to China, Singapore and South Korea。London：DTI。
3.	Drahos, P.、Braithwaite, J.(2002)。Information feudalism: who owns the knowledge economy?。London：Earthscan。
4.	European Commission, DG Research(2004)。Survey on opinions from national ethics committees or similar bodies, public debate and national legislation in relation to human embryonic stem cell research and use。Volume I: EU Member States。Brussels：European Commission。
5.	Franklin, S.(2004)。What we know and what we don’t about cloning and society。Reconfiguring nature: Issues and debates in the new genetics。Aldershot：Ashgate。
6.	Gottweis, Herbert(2007)。Rhetoric in Policy Making: Between Logos, Ethos, and Pathos。Handbook of Public Policy Analysis。Boca Raton：CRC Press。
7.	Haas, P. M.(2001)。Policy knowledge: epistemic communities。International Encyclopedia of the Social and Behavioral Sciences。
8.	May, C.、Sell, S.(2005)。Intellectual property rights: a critical history。Boulder Co：Lynnee Rieener。
9.	Nie, J. -B.(2005)。Behind the silence: Chinese voices on abortion。New York：Rowman and Littlefield Publishers Inc.。
10.	Parry, B. C.(2005)。Trading the genome: investigating the commodification of bio-information。New York：Columbia University Press。
11.	Parry, B. C.(2006)。Contested bodies: property models and the commodification of human biologicalartefacts。Science as Culture。
12.	Qiu, R.(2000)。Reshaping the concept of personhood: a Chinese perspective。The moral status of persons: perspective on bioethics。Amsterdam and Atlanta：Rodopi。
13.	Salter, B.(2007)。Bioethics, politics and the moral economy of human embryonic stem cell science: the case of the European Union’s Sixth Framework Programme。New Genetics and Society。
14.	Sleeboom-Faulkner, M.(2004)。Genomics in Asia: Cultural values and bioethical practices。London：Kegan Paul。
15.	UK Stem Cell Initiative(2011)。Report and recommendations。London：Department of Health。
16.	UNESCO(2001)。World Conference on Science: Science for the 21st Century--A new Commitment。Paris：UNESCO。
17.	Wang, Y.(2003)。Chinese ethical views on embryonic stem (ES) cell research。Asian bioethics in the 21st century。Bangkok：Eubios Ethics Institute。
18.	Jonsen, Albert R.(1998)。The Birth of Bioethics。Oxford University Press。
19.	Jasanoff, Sheila(2005)。Designs on nature: Science and democracy in Europe and the United States。Princeton University Press。
20.	Pickering, Andrew(1995)。The Mangle of Practice: Time, Agency, and Science。University of Chicago Press。
21.	Jasanoff, Sheila S.(2004)。States of Knowledge: The Co-production of Science and Social Order。Routledge。
22.	Andrews, Lori B.、Nelkin, Dorothy(2001)。Body bazaar: The market for human tissue in the biotechnology age。London：Crown。
23.	Waldby, Catherine、Mitchell, Robert(2006)。Tissue economies: Gifts, commodities, and biovalue in late capitalism。Durham, NC：Duke University Press。

其他
1.	Xu, G.，Minister of Science and Technology, People’s Republic of China(20060216)。China’s science and technology: towards the new era，Canberra, Australia。，http://wvsjw.science.org.an/events/16february06.htm。
2.	Corrigan O.，Liddell, K.，McMillan, J.，Stewart, A.，Wallace, S.(2006)。Ethical, legal and social issues in stem cell research and therapy，Cambridge：Cambridge Genetics。
3.	Knowledge Park，www.cgkp.org.uk。
4.	(2008)。China Stem Cell News，http://www.stemcellschina.com/， 2009/07/23。
5.	Human Genome Organization(2004)。Statement on stem cells，www.hugo-intemational.org/PDFs/Statement%20on%20Stem%20Cells%20%202004.pdf， 2010/05/10。
6.	Jia, H.(20060410)。China cracks down on malpractice in fertility industry，http://www.scidev.net/dossiers/index.cfm?fuseaction=dossierReadItem&type=l&itemid=2775&language=l&dossier=5&CFID=2592544&CFTOKEN=94836456， 2010/05/04。
7.	Kenney. M.，Han, K.，Tanaka, S.(2002)。Venture capital industries in East Asia，http://hcd.ucdavis.edu/faculty/kenney/articles/venturecapital/02_world_bank_l.doc， 2010/05/02。
8.	Ministry of Science and Technology(2007)。Regulation on Misconduct in Scientific Research，http://www.chinaphs.org/bioethics/regulations_&_laws.htm#_Toc 161968268。
9.	People’s Republic of China(2006)。China issues S & T guidelines，http://www.gov.cn/english/2006-02/09/content_l83426.htm， 2008/01/04。
10.	Qiu, R.(20070518)。China taking the right steps in bioethics，http://www.scidev.net/Opinions/index.cfm7fiiseaction=readOpinions&itemid=611&language=1， 2009/04/07。
11.	Watts. J.(20041201)。I don’t know how it works。

圖書論文
1.	Petryna, A.(2006)。Globalizing Human Subjects Research。Global pharmaceuticals: ethics, markets, practices。Durham：Duke University Press。

推文
推薦
引用網址
引用嵌入語法
轉寄

top

:::

相關期刊
相關論文
相關專書
相關著作
熱門點閱

無相關期刊論文

無相關博士論文

無相關書籍

無相關著作

1.	我國安寧緩和醫療及其相關立法爭議問題之研究

QR Code

臺灣人文及社會科學引文索引資料庫系統

詳目顯示

臺灣人文及社會科學引文索引資料庫